SMART Path 1.1 Implementation of Innovations

Frontline Biosciences expert commentary and recommendations

• The module can be utilized by both large entrepreneurs and consortium members, including research organizations and non-governmental organizations (NGOs)
• This represents a noteworthy improvement compared to previous EU funding programs, as it allows not only companies with SME status but also other entities to participate in implementation programs.
• The Innovation Implementation Module can serve as the foundation for projects carried out by SME companies. Such a project does not have to include the R&D Works Module.
• The requirements differ for large companies. If a company in this group wishes to undertake the Innovation Implementation Module, they must also incorporate the R&D Works Module within the same project plan.
• The FENG conditional grant applies only to the Innovation Implementation Module. It assumes partly non-refundable and partly refundable financing on preferential terms. More details are available in an article published by Market Insight.
• Projects carried out under the Innovation Implementation Module are an extension of the IR OP 1.1.1 “Fast Track” projects, which must be completed by December 2023. When implementing an R&D project supported by a grant, it is important to consider that leveraging another grant can be a beneficial step towards the successful commercialization of the solution.
• When preparing to participate in the Innovation Implementation Module, it is crucial to give special attention to the reliable documentation of the conducted R&D work. One of the aspects to be verified includes the costs that have already been incurred for the R&D work. Therefore, it is advisable to establish separate accounts specifically designated for recording costs associated with R&D work when engaging in research activities.